Delphinus Medical Technologies
Novi
About Delphinus Medical Technologies
Delphinus Medical Technologies develops, commercializes, sells, and services breast cancer screening solutions to hospitals and imaging clinics in the United States and internationally. It commercializes SoftVue, a three-dimensional and tomographic ultrasound imaging and risk assessment device that examines women's breasts for the presence of benign and/or malignant masses, assesses breast cancer risks, diagnoses breast diseases, and monitors therapy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $109.1M
- Last round: Series Unknown (Aug 2023)
- Website: delphinusmt.com
- Phone: 734-233-3088
Industries & Categories
Biotechnology, Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/delphinus-medical-technologies-50753 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.